Successful treatment of Kasabach-Merritt syndrome with pentoxifylline

Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.

Dale E. Hammerschmidt, Dusan Kotasek, Tyler James McCarthy et al. · PubMed · 1988 · 99 citations

Medicine, Hematology, Pharmacology +12

Kasabach-Merritt syndrome: therapeutic considerations.

Eric Larsen, William H. Zinkham, Joseph C. Eggleston et al. · PubMed · 1987 · 75 citations

Medicine, Hematology, Pediatrics +16

Kasabach-Merritt Syndrome: Therapeutic Considerations

Eric Larsen, William H. Zinkham, Joseph C. Eggleston et al. · PEDIATRICS · 1987 · 73 citations

Medicine, Hematology, Pediatrics +15

Intratumoral consumption of indium-111 labeled platelets in a patient with hemangiomatosis and intravascular coagulation (Kasabach-merritt syndrome)

Raymond P. Warrell, Sanford Kempin, Richard S. Benua et al. · Cancer · 1983 · 34 citations · Full text

Medicine, Oncology, Radiology +11

Pentoxifylline Inhibition of Procoagulant Activity Generated by Activated Mononuclear Phagocytes

Dominique de Prost, Véronique Ollivier, J Hakim · 2015 · 27 citations

Life Sciences, Immunology, Pharmacology +7